DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB: CONX), a worldwide developer and marketer of diagnostic test kits, has announced that its recently FDA cleared AspirinWorks® Test Kit is available to doctors nationwide. “We are pleased that AspirinWorks testing is now offered nationally through the LabCorp network of laboratories, making the test available to virtually every physician in the U.S.,” said Corgenix’ Clinical Affairs Director Gordon Ens. “This is in addition to our growing list of other clinical laboratories offering the test, such as Emory University in Atlanta.”
